Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV003525856 | SCV004292018 | uncertain significance | Catecholaminergic polymorphic ventricular tachycardia 1 | 2023-11-08 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 4860 of the RYR2 protein (p.Ala4860Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with RYR2-related conditions (PMID: 12093772). ClinVar contains an entry for this variant (Variation ID: 12963). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR2 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects RYR2 function (PMID: 25775566, 33536282). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| OMIM | RCV001813980 | SCV000034076 | pathogenic | Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome | 2007-11-13 | no assertion criteria provided | literature only |